Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M E Davis

Showing results (21-30 of 348) with videos related to

Pageof 35
Sort By:
Expert Opinion on Pharmacotherapy|October 6, 2018
Pharmacotherapy for the prevention of malaria in pregnant women: currently available drugs and challengesBrioni R Moore, Timothy M E Davis
Internal Medicine Journal|March 10, 2025
Incidence and predictors of transurethral resection of prostate in men with and without type 2 diabetes: the Fremantle Diabetes Study Phase ITimothy M E Davis, Wendy A Davis
Diabetic Medicine : a Journal of the British Diabetic Association|January 5, 2026
Incidence and associates of aortic valve replacement in people with or without type 2 diabetes: The Fremantle diabetes study phase IITimothy M E Davis, Wendy A Davis
Cardiovascular Diabetology|September 16, 2023
Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes StudyWendy A Davis, Timothy M E Davis
Diabetes, Obesity & Metabolism|December 11, 2023
An assessment of factors contributing to the decline in risk of stroke complicating type 2 diabetes: The Fremantle Diabetes StudyTimothy M E Davis, Wendy A Davis
Diabetes Research and Clinical Practice|October 19, 2010
Cardiovascular risk prediction in adults with type 1 diabetes: the Fremantle Diabetes StudyWendy A Davis, Timothy M E Davis
Diabetes Care|July 4, 2020
Influence of Renin-Angiotensin System Inhibitors on Lower-Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase IITimothy M E Davis, Wendy A Davis
Clinical Therapeutics|November 20, 2016
Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in PerspectivePeter L Thompson, Timothy M E Davis
Journal of Diabetes and Its Complications|April 21, 2019
The LEADER trial in type 2 diabetes: Were the characteristics and outcomes of the participants representative?Timothy M E Davis, Wendy A Davis
The American Journal of Tropical Medicine and Hygiene|February 7, 2014
Confirming cerebral malaria deaths in resource-limited settingsMoses Laman, Timothy M E Davis, Laurens Manning
Pageof 35

Showing results (21-30 of 348) with videos related to

Sort By:
Pageof 35
Expert Opinion on Pharmacotherapy|October 6, 2018
Pharmacotherapy for the prevention of malaria in pregnant women: currently available drugs and challengesBrioni R Moore, Timothy M E Davis
Internal Medicine Journal|March 10, 2025
Incidence and predictors of transurethral resection of prostate in men with and without type 2 diabetes: the Fremantle Diabetes Study Phase ITimothy M E Davis, Wendy A Davis
Diabetic Medicine : a Journal of the British Diabetic Association|January 5, 2026
Incidence and associates of aortic valve replacement in people with or without type 2 diabetes: The Fremantle diabetes study phase IITimothy M E Davis, Wendy A Davis
Cardiovascular Diabetology|September 16, 2023
Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes StudyWendy A Davis, Timothy M E Davis
Diabetes, Obesity & Metabolism|December 11, 2023
An assessment of factors contributing to the decline in risk of stroke complicating type 2 diabetes: The Fremantle Diabetes StudyTimothy M E Davis, Wendy A Davis
Diabetes Research and Clinical Practice|October 19, 2010
Cardiovascular risk prediction in adults with type 1 diabetes: the Fremantle Diabetes StudyWendy A Davis, Timothy M E Davis
Diabetes Care|July 4, 2020
Influence of Renin-Angiotensin System Inhibitors on Lower-Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase IITimothy M E Davis, Wendy A Davis
Clinical Therapeutics|November 20, 2016
Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in PerspectivePeter L Thompson, Timothy M E Davis
Journal of Diabetes and Its Complications|April 21, 2019
The LEADER trial in type 2 diabetes: Were the characteristics and outcomes of the participants representative?Timothy M E Davis, Wendy A Davis
The American Journal of Tropical Medicine and Hygiene|February 7, 2014
Confirming cerebral malaria deaths in resource-limited settingsMoses Laman, Timothy M E Davis, Laurens Manning
Pageof 35